|
BCKDHA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.4927173920305E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.70740113556189E-11 |
| Normal-vs-Stage2 |
4.91630000043486E-08 |
| Normal-vs-Stage3 |
8.76949999950583E-07 |
| Normal-vs-Stage4 |
5.037500E-04 |
| Stage1-vs-Stage2 |
4.035200E-01 |
| Stage1-vs-Stage3 |
7.038400E-01 |
| Stage1-vs-Stage4 |
9.545800E-01 |
| Stage2-vs-Stage3 |
7.175800E-01 |
| Stage2-vs-Stage4 |
5.981800E-01 |
| Stage3-vs-Stage4 |
8.228400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.213918268827E-12 |
| Normal-vs-AfricanAmerican |
1.43210000524974E-08 |
| Normal-vs-Asian |
1.139200E-03 |
| Caucasian-vs-AfricanAmerican |
9.101000E-01 |
| Caucasian-vs-Asian |
7.376400E-01 |
| AfricanAmerican-vs-Asian |
7.378400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.33866267965277E-12 |
| Normal-vs-Female |
2.85010000045105E-08 |
| Male-vs-Female |
7.018800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.38170000177851E-08 |
| Normal-vs-Extreme_Weight |
2.4624746686186E-12 |
| Normal-vs-Obese |
1.25969999986708E-07 |
| Normal-vs-Extreme_Obese |
2.856000E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.597800E-01 |
| Normal_Weight-vs-Obese |
4.814400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.883200E-01 |
| Extreme_Weight-vs-Obese |
1.193970E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.739200E-01 |
| Obese-vs-Extreme_Obese |
9.197600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.78700000019738E-07 |
| Normal-vs-Age(41-60Yrs) |
1.09590003738447E-09 |
| Normal-vs-Age(61-80Yrs) |
1.94639859785184E-11 |
| Normal-vs-Age(81-100Yrs) |
3.93629999995149E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.664600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.713000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.647800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.866600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.123000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.487200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.77902137465935E-12 |
| Normal-VS-Type2 PRCC |
1.02769999954511E-07 |
| Normal-VS-KIRP CIMP |
4.19789999994702E-06 |
| Normal-VS-Unclassified PRCC |
2.41469999995303E-07 |
| Type1 PRCC-VS-Type2 PRCC |
3.035600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.046200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.460600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.824620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.837000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.898600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.27610033651138E-10 |
| Normal-vs-N1 |
4.22139999955995E-07 |
| Normal-vs-N2 |
1.893510E-02 |
| N0-vs-N1 |
8.391400E-01 |
| N0-vs-N2 |
5.720200E-01 |
| N1-vs-N2 |
6.160200E-01 |
|
|
